Prognostic Accuracy of the HEART Score in Undifferentiated Chest Pain: A Multicenter Validation Study
1 other identifier
observational
4,267
1 country
3
Brief Summary
Chest pain remains one of the most common, potentially serious presenting complaints for adults emergency department visits with approximately 7.6 million yearly visits in the united states. The priority for emergency physician is to determine whether these patients with acute chest pain have a potential life threatening underlying etiology. The great challenge is to differentiate patients presenting with acute coronary syndrome and those with other more benign conditions. There is a global tendency for ED physician to over investigate chest pain patients , even in low-risk patients. This kind of practice leads to resource over-utilization and a huge health costs waste contrasting with no outcomes improvement. For many years, physicians have been searching tools, ranging from specific diagnostic tests to entire strategies of evaluation, to appropriately stratify the risk in patients with chest pain in order to simultaneously prevent major adverse cardiac events and reduce unnecessary testing and hospitalizations. Many bioclinical scores have been developed, such as the TIMI score and the GRACE score.The HEART score is one of the more recently proposed model derived through a process involving expert opinion and review of medical literature. It is calculated based on admission data of medical history, EKG, age, cardiovascular risk factors and troponin levels. The HEART score was created specifically to identify ED patients presenting with undifferentiated chest pain who were at low risk as well as patients at high risk of short-term MACE occurrence. HEART score has been widely reported to outperform the TIMI and the GRACE scores. Several scientific societies are encouraging the use of HEART score, for evaluating patients with chest pain suggestive of ACS in the ED. The goal of our investigation is to validate HEART score as a prognostication tool among ED patients with chest pain in teaching hospitals in Tunisia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2015
Typical duration for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2018
CompletedFirst Submitted
Initial submission to the registry
September 29, 2020
CompletedFirst Posted
Study publicly available on registry
October 8, 2020
CompletedMay 6, 2021
April 1, 2021
2.2 years
September 29, 2020
April 30, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Mace
Rate of MACE occurence including all-cause mortality, non-fatal myocardial infarction (MI), and coronary revascularisation within 30 days.
30 days
Eligibility Criteria
Patients aged over 30 years admitted to the ED with typical chest pain with an EKG not showing STEMI.
You may qualify if:
- Any adult aged older than 30 years.
- Chief complaint of ''chest pain'', ''chest tightness'', or ''chest pressure''.
You may not qualify if:
- Shortness of breath without chest pain
- ST elevation myocardial infarction (STEMI)
- Patients lost to follow up
- Patients with obvious diagnosis made immediately after initial medical evaluation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Sahloul University Hospital
Hammam Sousse, Sousse Governorate, 4011, Tunisia
Emergency department of university hospital Fattouma Bourguiba of Monastir Monastir, Monastir Tunisia
Monastir, 5000, Tunisia
Emergency department of university hospital Farhad Hached, Sousse
Sousse, 4000, Tunisia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nouira semir, MD
CHU fattouma Bourguiba Monastir
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professeur
Study Record Dates
First Submitted
September 29, 2020
First Posted
October 8, 2020
Study Start
January 1, 2015
Primary Completion
April 1, 2017
Study Completion
August 1, 2018
Last Updated
May 6, 2021
Record last verified: 2021-04